Insiders AnGes, Inc.

Equities

Market Closed - Japan Exchange Other stock markets 11:30:00 17/05/2024 am IST			5-day change	1st Jan Change
47 ^JPY	+2.17%		-4.08%	-34.72%

19/01	Eiger BioPharmaceuticals Gets Marketing Approval for Treatment of Ultra-Rare Genetic Disease	MT
18/01	Eiger BioPharmaceuticals, Inc. and Partner, AnGes, Inc. Receive Approval for Zokinvy for Hutchinson- Gilford Progeria Syndrome and Processing-Deficient Progeroid Laminopathies in Japan	CI

No results for this search